Physician profile
Richard E Seith
NPI 1396711511
$2,128.60
in general payments reported to CMS, 2019-2025
10 companies · $526 in 2025
The $526 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $126 · 2021: $454 · 2022: $178 · 2023: $470 · 2024: $374 · 2025: $526.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,370.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $462.61 | 2024-2025 | Photrexa Viscous and Photrexa, Istent Trabecular Micro-Bypass System Model Is3 |
| Alcon Vision LLC | $451.04 | 2020-2025 | Lensx, Argos |
| Allergan, INC. | $421.25 | 2021-2022 | |
| Rxsight INC | $267.55 | 2024-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Abbvie INC. | $232.28 | 2022-2025 | Durysta, Xen Glaucoma Treatment System |
| Sight Sciences, INC. | $149.58 | 2021-2025 | Omni Surgical System |
| Sun Pharmaceutical Industries INC. | $61.81 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $42.33 | 2024 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $24.02 | 2020 | |
| Bausch & Lomb Americas INC. | $16.13 | 2025 | Scoutpro Osmolarity System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Seith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.